Home
Beam Therapeutics Inc

Beam Therapeutics Inc Market Share Analysis for November 2025

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts.

Health > Biotechnology and Pharmaceuticals

Domainbeamtx.com

Year Founded2017

Employees501 - 1000

Annual Revenue$50M - $75M

Beam Therapeutics Inc

Beam Therapeutics Inc (including company regionals)

beamtx.com

See more website traffic and engagement information

Beam Therapeutics Inc Revenue up to November 2025 is 50M - 75M

revenue generated by Beam Therapeutics Inc top domains

Beam Therapeutics Inc top domains revenue over 3 years

Revenue for Beam Therapeutics Inc top domains

beamtx.com50M - 75M

See more with Sales Intelligence

Total visits to Beam Therapeutics Inc's top domains

Understand Beam Therapeutics Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

beamtx.com40.4K

See more with Sales Intelligence

Avg. visit duration in Beam Therapeutics Inc's top domains

Analyze Beam Therapeutics Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

beamtx.com00:01:21

See more with Sales Intelligence

Avg. pageviews on Beam Therapeutics Inc's top domains

See how Beam Therapeutics Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

beamtx.com2.48

See more with Sales Intelligence

Beam Therapeutics Inc top competitors by domain

Top similar sites in November 2025, ranked by their affinity

akebia.comCompany NameAkebia Therapeutics, Inc.Employees201 - 500HQUnited States, Massachusetts, CambridgeAnnual revenue$200M - $500MTotal visits9.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Beam Therapeutics Inc

These are the website technologies, by industry, used by Beam Therapeutics Inc top domains

Mobile (3)

Meta Viewport

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Business Solutions (1)

DocuSign

More Technologies

7

See all

News & Signals from Beam Therapeutics Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBeam Therapeutics Inc. attends event European Hematology Association 2025 Congress.Beam Therapeutics (NASDAQ: BEAM), a biotechnology firm pioneering precision genetic medicines via base editing, announced it will present updated data from its BEACON Phase 1/2 trial of BEAM-101 at the European Hematology Association 2025 Congress, June 12-15 in Milan.

NewsBeam Therapeutics Inc. attended event 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress on Apr 5th '25.CAMBRIDGE, Mass., April 05, 2025 (GLOBE NEWSWIRE) - Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today presented additional data from the Phase 1/2 clinical trial of BEAM-302 in patients with alpha-1 antitrypsin deficiency (AATD) at the 2025 Alpha-1 Foundation 7th Global Research Conference and 10th Patient Congress, taking place April 4-5, 2025, in Lisbon, Portugal.

NewsBeam Therapeutics Inc. attends event Guggenheim SMID Cap Biotech Conference.Beam Therapeutics to participate in Guggenheim SMID Cap Biotech Conference.